These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10887495)

  • 1. The role of cadherin-mediated adhesion in breast cancer.
    Sommers CL
    J Mammary Gland Biol Neoplasia; 1996 Apr; 1(2):219-29. PubMed ID: 10887495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cadherin junctions in mammary tumors.
    Wheelock MJ; Soler AP; Knudsen KA
    J Mammary Gland Biol Neoplasia; 2001 Jul; 6(3):275-85. PubMed ID: 11547897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis.
    Hazan RB; Phillips GR; Qiao RF; Norton L; Aaronson SA
    J Cell Biol; 2000 Feb; 148(4):779-90. PubMed ID: 10684258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkyl-lysophospholipid 1-O-octadecyl-2-O-methyl- glycerophosphocholine induces invasion through episialin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro.
    Steelant WF; Goeman JL; Philippé J; Oomen LC; Hilkens J; Krzewinski-Recchi MA; Huet G; Van der Eycken J; Delannoy P; Bruyneel EA; Mareel MM
    Int J Cancer; 2001 May; 92(4):527-36. PubMed ID: 11304687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammary tumors initiated by constitutive Cdk2 activation contain an invasive basal-like component.
    Corsino PE; Davis BJ; Nørgaard PH; Parker NN; Law M; Dunn W; Law BK
    Neoplasia; 2008 Nov; 10(11):1240-52. PubMed ID: 18953433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model.
    Ribeiro AS; Sousa B; Carreto L; Mendes N; Nobre AR; Ricardo S; Albergaria A; Cameselle-Teijeiro JF; Gerhard R; Söderberg O; Seruca R; Santos MA; Schmitt F; Paredes J
    J Pathol; 2013 Apr; 229(5):705-18. PubMed ID: 23180380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cadherins and catenins in breast cancer.
    Cowin P; Rowlands TM; Hatsell SJ
    Curr Opin Cell Biol; 2005 Oct; 17(5):499-508. PubMed ID: 16107313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
    De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
    J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
    Yoshida R; Kimura N; Harada Y; Ohuchi N
    Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin.
    Wong AS; Gumbiner BM
    J Cell Biol; 2003 Jun; 161(6):1191-203. PubMed ID: 12810698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-cadherin role in normal breast development and cancer.
    Albergaria A; Ribeiro AS; Vieira AF; Sousa B; Nobre AR; Seruca R; Schmitt F; Paredes J
    Int J Dev Biol; 2011; 55(7-9):811-22. PubMed ID: 22161837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
    de Groot JS; Ratze MA; van Amersfoort M; Eisemann T; Vlug EJ; Niklaas MT; Chin SF; Caldas C; van Diest PJ; Jonkers J; de Rooij J; Derksen PW
    J Pathol; 2018 Aug; 245(4):456-467. PubMed ID: 29774524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-cadherin promotes adhesion between invasive breast cancer cells and the stroma.
    Hazan RB; Kang L; Whooley BP; Borgen PI
    Cell Adhes Commun; 1997 Mar; 4(6):399-411. PubMed ID: 9177902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone decreases levels of the adhesion protein E-cadherin and promotes invasiveness of steroid receptor positive breast cancers.
    Kariagina A; Xie J; Langohr IM; Opreanu RC; Basson MD; Haslam SZ
    Horm Cancer; 2013 Dec; 4(6):371-80. PubMed ID: 23996076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of retinal cadherin facilitates mammary tumor progression and metastasis.
    Agiostratidou G; Li M; Suyama K; Badano I; Keren R; Chung S; Anzovino A; Hulit J; Qian B; Bouzahzah B; Eugenin E; Loudig O; Phillips GR; Locker J; Hazan RB
    Cancer Res; 2009 Jun; 69(12):5030-8. PubMed ID: 19491271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
    Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO
    J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of E-cadherin and catenins in invasive mammary carcinomas.
    Zschiesche W; Schönborn I; Behrens J; Herrenknecht K; Hartveit F; Lilleng P; Birchmeier W
    Anticancer Res; 1997; 17(1B):561-7. PubMed ID: 9066580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
    Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.